Quarterly Transactions Made in Viridian Therapeutics, Inc.\De (VRDN)
This table provides information about the institutional ownership of Viridian Therapeutics, Inc.\De (VRDN). The information is specifically focused on institutions that hold shares of Viridian Therapeutics, Inc.\DE.
Shares Purchased
Shares Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2021 | 2,958,994 | 5,786,407 | 8,745,401 | 311,801 | 788,538 | 1,100,339 | 7,645,062 | |
Q4 2021 | 4,448,849 | 6,206,551 | 10,655,400 | 621,869 | 1,508,534 | 2,130,403 | 8,524,997 | |
Q1 2022 | 1,425,026 | 2,469,101 | 3,894,127 | 1,013,333 | 1,538,928 | 2,552,261 | 1,341,866 | |
Q2 2022 | 6,094,701 | 1,090,972 | 7,185,673 | 2,785,350 | 1,736,380 | 4,521,730 | 2,663,943 | |
Q3 2022 | 9,407,815 | 4,398,440 | 13,806,255 | 2,454,010 | 0 | 2,454,010 | 11,352,245 | |
Q4 2022 | 5,712,217 | 3,461,623 | 9,173,840 | 4,015,947 | 0 | 4,015,947 | 5,157,893 | |
Q1 2023 | 5,830,292 | 3,712,939 | 9,543,231 | 6,734,802 | 0 | 6,734,802 | 2,808,429 | |
Q2 2023 | 7,178,882 | 2,393,242 | 9,572,124 | 1,885,951 | 0 | 1,885,951 | 7,686,173 | |
Q3 2023 | 5,616,932 | 2,202,012 | 7,818,944 | 2,172,037 | 0 | 2,172,037 | 5,646,907 | |
Q4 2023 | 14,733,819 | 5,417,150 | 20,150,969 | 6,068,156 | 0 | 6,068,156 | 14,082,813 | |
Q1 2024 | 11,948,403 | 4,697,308 | 16,645,711 | 2,701,929 | 0 | 2,701,929 | 13,943,782 | |
Q2 2024 | 9,924,644 | 542,522 | 10,467,166 | 10,115,916 | 0 | 10,115,916 | 351,250 | |
Q3 2024 | 14,206,740 | 9,665,331 | 23,872,071 | 4,150,284 | 0 | 4,150,284 | 19,721,787 |